Serum autotaxin as a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.
Takashi ArakiTakahiro OkumuraHiroaki HiraiwaTakashi MizutaniYuki KimuraShingo KazamaNaoki ShibataHideo OishiTasuku KuwayamaToru KondoRyota MorimotoMikito TakefujiToyoaki MuroharaPublished in: ESC heart failure (2022)
High serum ATX levels can be associated with increasing adverse clinical outcomes in patients with NIDCM. These results indicate serum ATX may be a novel biomarker or therapeutic target in NIDCM.
Keyphrases